Model
Edge
Cero Therapeutics Holdings, Inc.
PBAX
Filing type
10-Q
Filing date
Nov 18, 2025
Updated
Nov 19, 2025 ยท 2:10 PM
Copy reference
Filing
10-Q
Q3
Exhibits
EX-10.5
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT, BY AND AMONG CERO THERAPEUTICS HOLDINGS, INC. AND THE INVESTORS SIGNATORY THERETO, DATED AS OF OCTOBER 16, 2025
EX-10.6
FORM OF AMENDMENT AND LIMITED WAIVER AGREEMENT, BY AND AMONG CERO THERAPEUTICS HOLDINGS, INC. AND THE HOLDERS SIGNATORY THERETO, DATED AS OF AUGUST 13, 2025
EX-31.1
CERTIFICATION
EX-31.2
CERTIFICATION
EX-32.1
CERTIFICATION
EX-32.2
CERTIFICATION